(Q41220602)

28 September 2017

Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma (English)

1 reference

28 September 2017

1 reference

D J Grimes

1

1 reference

28 September 2017

M R Bowles

2

1 reference

28 September 2017

J A Buttsworth

3

1 reference

28 September 2017

D B Thomson

4

1 reference

28 September 2017

P J Ravenscroft

5

1 reference

28 September 2017

P F Nixon

6

1 reference

28 September 2017

R F Whiting

7

1 reference

28 September 2017

S M Pond

8

1 reference

28 September 2017

1 November 1990

1 reference

28 September 2017

1 reference

28 September 2017

5

1 reference

28 September 2017

6

1 reference

28 September 2017

447-454

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199005060-00005

28 September 2017

0 references

cites work

Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose

1 reference

12 December 2020

Modification of human serum albumin binding of methotrexate by folinic acid and certain drugs used in cancer chemotherapy

1 reference

12 December 2020

Renal toxicity of methotrexate

1 reference

12 December 2020

Protein-methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy.

1 reference

12 December 2020

Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration

1 reference

12 December 2020

Folinic acid: pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine

1 reference

12 December 2020

Clinical Pharmacokinetics of Methotrexate1

1 reference

12 December 2020

Role of repeated oral doses of activated charcoal in clinical toxicology

1 reference

12 December 2020

Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy

1 reference

12 December 2020

The effect of high-dose methotrexate on renal tubules as indicated by urinary lysozyme concentration

1 reference

12 December 2020

The protein binding and elimination of methotrexate after intravenous infusions in cancer patients

1 reference

12 December 2020

Recovery from toxicity associated with high-dose methotrexate: prognostic factors

1 reference

12 December 2020

Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon

1 reference

12 December 2020

Prolongation and enhancement of serum methotrexate concentrations by probenecid

1 reference

12 December 2020

Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate

1 reference

12 December 2020

Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate

1 reference

12 December 2020

Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insufficiency

1 reference

12 December 2020

The clinical pharmacology of methotrexate.new applications of an old drug

1 reference

12 December 2020

Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate

1 reference

12 December 2020

Hemoperfusion for methotrexate removal

1 reference

12 December 2020

10.2165/00002018-199005060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

28 September 2017

0 references

1 reference